FDA Approves Sanofi Wearable for Multiple Myeloma Treatment

By Ed Silverman · STAT News · 2026-07-13

FDA Approves Sanofi Wearable for Multiple Myeloma Treatment

The Food and Drug Administration has authorized a new on-body delivery system for Sanofi’s Sarclisa, as reported by STAT News. This change allows patients with blood cancer to move away from traditional intravenous infusions. Federal health officials are also convening experts to

The Food and Drug Administration has authorized a new on-body delivery system for Sanofi’s Sarclisa, as reported by STAT News. This change allows patients with blood cancer to move away from traditional intravenous infusions. Federal health officials are also convening experts to